Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…sim MT. Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension. Trends Pharmacol. Sci. 2021;42:510–513Osei-Wusuansa M, Mohamme…
…of the included children had advanced BA, one-fifth of them had PAH impairment and two-thirds exhibited insulin resistance. Advance…
…Pulmonary arterial hypertension (PAH) is a severe and progressive disease characterised by exce…
…the lung and its overexpression has been recently implicated in pulmonary arterial hypertension (PAH). In a mouse model of hypoxia-induced PAH, mice with a targeted …
… VVDs are commonly used in SSc to treat digital ulcers (DU) and Raynaud’s phenomenon, we investigated the effectiveness of VVD on the primary preven…
…rted in 12(35%), interstitial lung disease (ILD) in 7 (21%) and pulmonary arterial hypertension (PAH) in five (15%)Among non-Ashkenazi (Sephardic and mixed ori…
… EUSTAR centers 254 and 255.Results A total of 60 patients with systemic sclerosis (SSc) were included (diffuse cutaneous: 46.7%; limited cutaneous: 53.…
…Introduction Systemic sclerosis (SSc) is an immune-mediated connective tissue disorder characte…
…test decline with an AAPC of -1.21.Conclusion During 1990–2019, pulmonary arterial hypertension has witnessed a statistically significant decline in incidence …
…Introduction Pulmonary Veno-Occlusive Disease (PVOD) is a very rare subtype of pulmonary arterial hypertensio…
… (HR 0.49; 95% CI:0.36-0.67, p<0.001) (figure 2).Conclusions In lcSSc, clinically meaningful progression, defined by MINIMISE endpoin…
…om unselected patients with SSc and compared with patients with rheumatoid arthritis (RA, n = 109) and healthy controls (n = 71). Optical density (O…